Evidence map›Paper›PMID 41059175›Full record

ArticleFrontiers in public health2025

Substance use risk screening and associated factors among Costa Rican secondary students: a nationally representative analysis.

Andrea Lopez-Soto, Esmeralda Ramirez, Jeancarlo Cordoba, Pablo Montero-Zamora

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea Lopez-SotoDepartment of Kinesiology and Health Education, University of Texas at Austin, Austin, TX, United States.
Esmeralda RamirezDepartment of Kinesiology and Health Education, University of Texas at Austin, Austin, TX, United States.
Jeancarlo CordobaSchool of Public Health, University of Costa Rica, San Jose, Costa Rica.
Pablo Montero-ZamoraDepartment of Kinesiology and Health Education, University of Texas at Austin, Austin, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adolescent substance use (SU) is a significant public health concern in Latin America, however, representative data to guide prevention efforts remain limited. This study examined SU risk and potential associated factors among Costa Rican secondary students using the CRAFFT 2.1 screening tool. Methods: Data were drawn from the 2021 VI National Survey on Psychoactive Substance Use in the Secondary School Population, a nationally representative sample of 3,524 students (weighted Results: Overall, 64.7% of students were classified as low-risk, 26.6% medium-risk, and 8.7% high-risk. Older age, substance use by family members (i.e., smoking and illicit drug use), sexual activity under SU, and exposure to psychological and sexual violence were all associated with increased odds of classification into the high-risk group. Sexual activity under SU was strongly associated with membership in the high-risk group compared to both low- and medium-risk groups. Conclusion: This study is the first to apply the CRAFFT tool to a nationally representative sample of Costa Rican adolescents, providing critical insights for prevention initiatives in Latin America. Findings emphasize the need for universal multi-level prevention interventions to delay SU initiation and promote prosocial environments that support healthy youth development, ultimately reducing the burden of SU among Costa Rican adolescents.

Indexed as

Adolescent BehaviorMass ScreeningStudentsSubstance-Related DisordersAdolescentCosta RicaFemaleHumansMaleRisk FactorsSchoolsSexual BehaviorSurveys and Questionnairesadolescent substance useCosta RicaCRAFFT screenernational surveyscreening toolviolence

Identifiers

PMID41059175
PMCPMC12497720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.